Dr. Bruce M. Wenig, MD

Dr. Wenig practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Dr. Wenig's NPI, 1578562575, was assigned on July 20, 2005. Dr. Wenig graduated from Tel Aviv University Sackler in 1981. Dr. Wenig holds Florida license ME60205.

Dr. Wenig's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

Dr. Wenig's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dr. Wenig is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Wenig to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wenig practices, 3 sites in all. Vendor and product names are available with a free account.

Anatomic pathology is Dr. Wenig's primary specialty in the NPI Registry, under taxonomy code 207ZP0101X. Dr. Wenig is board certified in anatomic pathology & clinical pathology by the American Board of Pathology. Dmand AI has Dr. Wenig's licenses on file in 12 states: Florida, District of Columbia, Maine, California, New York, Utah, Indiana, Michigan, Louisiana, Minnesota, Delaware and Virginia.

CMS data shows 1,291 Medicare services from Dr. Wenig across 12 procedure codes in 2024, for 350 Medicare patients. Medicare paid $46,805 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 350 Medicare patients who saw Dr. Wenig in 2024. The largest group is 65 to 74, with 170 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wenig's median patient age at 67, with 50% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Wenig for performance year 2024, reported as part of a group. Dr. Wenig accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 131 papers to Dr. Wenig, published from 2011 to 2025. 2015 was the busiest year, with 5. The most frequent topics are Immunohistochemistry, Thyroid Neoplasms and Diagnosis, Differential. Dr. Wenig has published most often in Head Neck Pathol. Dr. Wenig's most frequent co-authors are Lester D. R. Thompson, MD, Justin Avery Bishop, MD and Christine H. Chung, MD.

CMS Open Payments shows 27 general payments to Dr. Wenig from 1 drug or device company from 2023 to 2025. Travel and lodging make up the largest share, 67% of the total. Merck Sharp & Dohme Corporation paid the most, $31,887.

Dmand AI lists 3 awards for Dr. Wenig, most recently New York Magazine: Top Doctors in 2016.

Dr. Wenig graduated from Tel Aviv University Sackler in 1981.

Dr. Wenig is in network with 5 carriers, including Excellus BlueCross BlueShield, CMS Medicare and Elevance. Medicaid plans come from the most carriers, 2. Check the plan with the practice before a visit.